Loading…

Intramasseteric spindle cell hemangioendothelioma: A rare case report with review of literature

Spindle cell hemangioendothelioma (SCH) was first described in 1986 by Weiss and Enzinger as a vascular neoplasm, characterized by cavernous blood vessels and spindled areas reminiscent of Kaposi’s sarcoma. The head and neck region is rarely involved with extremely rare muscular involvement; this be...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oral and maxillofacial surgery, medicine, and pathology medicine, and pathology, 2018-07, Vol.30 (4), p.346-349
Main Authors: Singh, Gaurav, Mishra, Madan, Gaur, Amit, Tewari, Abhivyakti, Dewan, Udita, Parashar, Nidhi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Spindle cell hemangioendothelioma (SCH) was first described in 1986 by Weiss and Enzinger as a vascular neoplasm, characterized by cavernous blood vessels and spindled areas reminiscent of Kaposi’s sarcoma. The head and neck region is rarely involved with extremely rare muscular involvement; this being the first case of intramasseteric SCH. A 30 year old male presented with a 2-year history of a painless, slow growing swelling on the left side of face. Fine needle aspiration cytology and Magnetic Resonance Imaging revealed it to be a vascular malformation. As the lesion did not respond to intralesional sclerotherapy, the lesion was surgically excised under general anaesthesia. The final diagnosis was aided by histopathological analysis and immunohistochemistry which revealed the lesion to be an intramassteric spindle cell hemangioendothelioma. On reviewing the literature, it can be established that spindle cell hemangioendothelioma is an unusual vascular tumor of the head and neck that is important to recognize to avoid misdiagnosis. Immunohistochemistry is considered as the final diagnostic aid and local surgical excision has been the most accepted treatment modality.
ISSN:2212-5558
2212-5566
DOI:10.1016/j.ajoms.2018.02.010